| Mechanisms and therapeutic implications of hypermutation in gliomas M Touat, YY Li, AN Boynton, LF Spurr, JB Iorgulescu, CL Bohrson, ... Nature 580 (7804), 517-523, 2020 | 464 | 2020 |
| Mitochondrial quality control during inheritance is associated with lifespan and mother–daughter age asymmetry in budding yeast JR McFaline‐Figueroa, J Vevea, TC Swayne, C Zhou, C Liu, G Leung, ... Aging cell 10 (5), 885-895, 2011 | 232 | 2011 |
| Brain tumors JR McFaline-Figueroa, EQ Lee The American journal of medicine 131 (8), 874-882, 2018 | 218 | 2018 |
| Role for cER and Mmr1p in anchorage of mitochondria at sites of polarized surface growth in budding yeast TC Swayne, C Zhou, IR Boldogh, JK Charalel, JR McFaline-Figueroa, ... Current biology 21 (23), 1994-1999, 2011 | 118 | 2011 |
| Deep‐learning detection of cancer metastases to the brain on MRI M Zhang, GS Young, H Chen, J Li, L Qin, JR McFaline‐Figueroa, ... Journal of Magnetic Resonance Imaging 52 (4), 1227-1236, 2020 | 96 | 2020 |
| The viral connection to glioblastoma JR McFaline-Figueroa, PY Wen Current infectious disease reports 19, 1-5, 2017 | 44 | 2017 |
| when less is more: dexamethasone dosing for brain tumors MJ Lim-Fat, WL Bi, J Lo, EQ Lee, MS Ahluwalia, TT Batchelor, SM Chang, ... Neurosurgery 85 (3), E607-E608, 2019 | 22 | 2019 |
| A pilot study of axicabtagene ciloleucel (axi-cel) for the treatment of relapsed/refractory primary and secondary central nervous system lymphoma (CNSL) CA Jacobson, C Falvey, R Bouvier, S Hogan, E Kendricken, J Jones, ... Blood 140 (Supplement 1), 1060-1061, 2022 | 19 | 2022 |
| Clinical utility of targeted next-generation sequencing assay in IDH-wildtype glioblastoma for therapy decision-making MJ Lim-Fat, GC Youssef, M Touat, JB Iorgulescu, S Whorral, M Allen, ... Neuro-oncology 24 (7), 1140-1149, 2022 | 18 | 2022 |
| Divergent roles of PI3K isoforms in PTEN-deficient glioblastomas S Xie, J Ni, JR McFaline-Figueroa, Y Wang, RT Bronson, KL Ligon, ... Cell reports 32 (13), 2020 | 18 | 2020 |
| Evaluation of standard response assessment in neuro-oncology, modified response assessment in neuro-oncology, and immunotherapy response assessment in neuro-oncology in newly … G Youssef, R Rahman, C Bay, W Wang, MJ Lim-Fat, O Arnaout, WL Bi, ... Journal of Clinical Oncology 41 (17), 3160-3171, 2023 | 17 | 2023 |
| Telomerase inhibition is an effective therapeutic strategy in TERT promoter-mutant glioblastoma models with low tumor volume E Aquilanti, L Kageler, J Watson, DM Baird, RE Jones, M Hodges, ... Neuro-oncology 25 (7), 1275-1285, 2023 | 11 | 2023 |
| A low percentage of metastases in deep brain and temporal lobe structures TK Yanagihara, JR McFaline-Figueroa, NJ Giacalone, AW Lee, V Soni, ... Neuro-oncology 21 (5), 640-647, 2019 | 11 | 2019 |
| Negative trials over and over again: How can we do better? JR McFaline-Figueroa, PY Wen Neuro-oncology 25 (1), 1-3, 2023 | 10 | 2023 |
| Inaugural results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A phase II platform trial for newly diagnosed glioblastoma using Bayesian adaptive … R Rahman, L Trippa, EQ Lee, I Arrillaga-Romany, G Fell, M Touat, ... Journal of Clinical Oncology 41 (36), 5524-5535, 2023 | 9 | 2023 |
| Brain MRS glutamine as a biomarker to guide therapy of hyperammonemic coma AH O'Donnell-Luria, AP Lin, SK Merugumala, F Rohr, SE Waisbren, ... Molecular Genetics and Metabolism 121 (1), 9-15, 2017 | 9 | 2017 |
| CTNI-12. Preliminary results of the abemaciclib arm in the individualized screening trial of innovative glioblastoma therapy (INSIGHT): a phase II platform trial using Bayesian … P Wen, L Trippa, E Lee, G Fell, R Rahman, I Arrillaga-Romany, M Touat, ... Neuro-Oncology 22 (Supplement_2), ii44-ii44, 2020 | 8 | 2020 |
| Biology and treatment of meningiomas: a reappraisal JR McFaline-Figueroa, TJ Kaley, IF Dunn, WL Bi Hematology/Oncology Clinics 36 (1), 133-146, 2022 | 5 | 2022 |
| Defects in mitochondrial distribution during the prolonged lag phase of Saccharomyces cerevisiae preceding growth in glycerol as the sole source of carbon J McInnes, M Rehders, JR McFaline-Figueroa, K Brix, LA Pon, E Nevoigt FEMS Yeast Research 13 (7), 706-710, 2013 | 5 | 2013 |
| Is it time to reconsider the role of irinotecan for the treatment of high-grade gliomas? EQ Lee, JR McFaline-Figueroa, TF Cloughesy, PY Wen Neuro-oncology 20 (8), 1144-1144, 2018 | 4 | 2018 |
Wenya Linda BiDept. of Neurosurgery, Brigham and Women's HospitalVerified email at partners.org
